Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.43 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | PPARA | Q07869 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Naphthol SCHEMBL10575743 | 0.81 | CYP1A2 (0.55) | SLC7A5SLC1A3SLC1A2SLC1A1PPARG | |
| Naphthoic Acid SCHEMBL10392235 | 0.80 | NR4A1 (0.66) | SLC7A5SLC1A3SLC1A2SLC1A1PPARG | |
| Valine SCHEMBL28052598 | 0.78 | SLC7A5 (0.88) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| Valine SCHEMBL4582565 | 0.78 | SLC7A5 (0.88) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| Benz(B)Anthracene SCHEMBL9710284 | 0.78 | SLC7A5 (0.58) | SLC7A5SLC1A3SLC1A2SLC1A1ALDH1A1 | |
| Acetic Acid SCHEMBL29538855 | 0.76 | ALDH1A1 (0.50) | KDM4EGAAKMT2AALDH1A1CYP1A2 | |
| Acetic Acid SCHEMBL28706282 | 0.76 | ALDH1A1 (0.50) | KDM4EGAAKMT2AALDH1A1CYP1A2 | |
| Acetic Acid SCHEMBL28736368 | 0.76 | ALDH1A1 (0.50) | KDM4EGAAKMT2AALDH1A1CYP1A2 | |
| Carbamic Acid SCHEMBL15123720 | 0.76 | ALDH1A1 (0.50) | KDM4EGAAKMT2AALDH1A1CYP1A2 | |
| Carbamic Acid SCHEMBL9232567 | 0.76 | ALDH1A1 (0.50) | KDM4EGAAKMT2AALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2608874-A1 | SEPARATION OF NANOPARTICLES | Yeda Research and Development Co. Ltd. (IL) | 2013-07-03 | — | — | EP | claimed |
| WO-2012025928-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) | 2012-03-01 | — | — | WO | claimed |
| WO-2000052099-A1 | BICHROMOPHORIC PERYLENE-3,4-DICARBOXIMIDES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-09-08 | — | — | WO | claimed |
| US-9623381-B2 | Separation of nanoparticles | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-04-18 | — | — | US | disclosed |
| EP-3112013-A1 | PERYLENE DIIMDE BASED MEMBRANE, PREPARATION AND RECYCLING THEREOF, AND USE FOR NANOPARTICLE SEPARATION THEREOF | Yeda Research and Development Co. Ltd (IL) | 2017-01-04 | — | — | EP | disclosed |
| US-20150375180-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-12-31 | — | — | US | disclosed |
| US-9067181-B2 | Separation of nanoparticles | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (US) | 2015-06-30 | — | — | US | disclosed |
| US-20130303769-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO. LTD (IL) | 2013-11-14 | — | — | US | disclosed |
| EP-2608874-A1 | SEPARATION OF NANOPARTICLES | Yeda Research and Development Co. Ltd. (IL) | 2013-07-03 | — | — | EP | disclosed |
| WO-2012025928-A1 | SEPARATION OF NANOPARTICLES | YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150375180-A1 | SEPARATION OF NANOPARTICLES | NCL, CD63, PARN | SLC7A5 1112/4885SLC1A3 2314/4885SLC1A2 2889/4885 |
| US-20130303769-A1 | SEPARATION OF NANOPARTICLES | NCL, CD63, PARN | SLC7A5 1112/4885SLC1A3 2314/4885SLC1A2 2889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.